James Lousararian
Amministratore Delegato presso Verax Biomedical, Inc.
Profilo
Jim Lousararian, JD, joined BioVentures Investors as a Managing Director in 2017, after previously being involved with multiple BioVentures Investors portfolio companies.
He brings over 20 years of entrepreneurship in the life sciences and healthcare sectors.
Jim has cultivated a career as a serial entrepreneur, including having been a co-founder and/or CEO of four life sciences start-ups, including three BioVentures portfolio companies: Verax Biomedical, where he remains as CEO; AngioLink, which sold to Medtronic in 2004; and Spirus, which was sold to Olympus in 2011.
In addition, Jim was also a Co-founder of ArthroSurface Incorporated, which was acquired by Anika Therapeutics in 2020, and co-founded Nursery Products, which was sold to Synagro, in the environmental services area.
Prior to the founding of AngioLink, Jim was a part of the management team of Thermo Electron that was instrumental in building their environmental services and remediation businesses and who took Thermo ReTec Corp.
public on the American Stock Exchange in 1993.
While at Thermo ReTec, Jim was President of two major environmental subsidiaries and responsible for sales and marketing and business development.
In addition, he led three turnarounds of troubled divisions.
Jim started at Thermo as Associate General Counsel.
Jim currently serves as CEO of Verax Biomedical and on the Board of Directors for Verax, Triopsy Medical and Unified Information Devices.
Jim previously served on the Board of CareSignal prior to its acquistion in Q4 2021.
Jim just completed a term as President of the Board of Trustees of the Wheeler School in Providence, Rhode Island.
He began his career at Hale and Dorr (now Wilmer Hale), a Boston law firm, and was previously an advisor to Point Judith Capital.
He holds a BBA degree in accounting from the University of Massachusetts, Amherst and a JD from the University of Chicago.
Posizioni attive di James Lousararian
| Società | Posizione | Inizio |
|---|---|---|
Verax Biomedical, Inc.
 Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Amministratore Delegato | 01/02/2006 |
BioVentures Investors
 BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | Investitore di Private Equity | - |
Precedenti posizioni note di James Lousararian
| Società | Posizione | Fine |
|---|---|---|
| Hale & Dorr LLP | Corporate Officer/Principal | - |
ThermoRetec Corp.
 ThermoRetec Corp. Environmental ServicesIndustrial Services ThermoRetec Corp. provides environmental services in the United states. The company was founded by Jeffrey L. Powell and is headquartered in Concord, MA. | Corporate Officer/Principal | - |
Primo Medical Group, Inc.
 Primo Medical Group, Inc. Medical SpecialtiesHealth Technology Primo Medical Group, Inc. designs and manufactures medical devices and precision machined components. It offers outsourcing solutions to the medical device market, including OEM product distribution services, engineering services, precision component production and finished goods assembly, refurbishment of medical devices, reusable surgical kit management and complete supply chain management. The company was founded in 1953 by Primo Tallarida and is headquartered in Stoughton, MA. | Direttore operativo | - |
Angiolink Corp.
 Angiolink Corp. Medical SpecialtiesHealth Technology AngioLink Corp. operated as a medical device company that has developed a four-pronged vascular stapling system, the EVS vascular closure system. It's EVS (expanding vascular stapling) vascular closure system, is engineered to close the femoral artery access site after vascular procedures, such as diagnostic angiography, balloon angioplasty and stenting. The company was headquartered in Taunton, MA. | Fondatore | - |
| Medtronic Vascular, Inc. | Corporate Officer/Principal | - |
Formazione di James Lousararian
| The University of Chicago | Graduate Degree |
| University of Massachusetts | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Point Judith Management Co LLC.
 Point Judith Management Co LLC. Investment ManagersFinance Point Judith Management Co LLC (Point Judith Capital Partner) is a venture capital firm founded in 2001 by David Martirano and Gina Raimondo. The firm is headquartered in Boston, Massachusetts. | Finance |
Verax Biomedical, Inc.
Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Commercial Services |
| Medtronic Vascular, Inc. | |
Angiolink Corp.
Angiolink Corp. Medical SpecialtiesHealth Technology AngioLink Corp. operated as a medical device company that has developed a four-pronged vascular stapling system, the EVS vascular closure system. It's EVS (expanding vascular stapling) vascular closure system, is engineered to close the femoral artery access site after vascular procedures, such as diagnostic angiography, balloon angioplasty and stenting. The company was headquartered in Taunton, MA. | Health Technology |
Primo Medical Group, Inc.
Primo Medical Group, Inc. Medical SpecialtiesHealth Technology Primo Medical Group, Inc. designs and manufactures medical devices and precision machined components. It offers outsourcing solutions to the medical device market, including OEM product distribution services, engineering services, precision component production and finished goods assembly, refurbishment of medical devices, reusable surgical kit management and complete supply chain management. The company was founded in 1953 by Primo Tallarida and is headquartered in Stoughton, MA. | Health Technology |
ThermoRetec Corp.
ThermoRetec Corp. Environmental ServicesIndustrial Services ThermoRetec Corp. provides environmental services in the United states. The company was founded by Jeffrey L. Powell and is headquartered in Concord, MA. | Industrial Services |
| Hale & Dorr LLP | Commercial Services |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | Finance |
- Borsa valori
- Insiders
- James Lousararian
